Clinical diagnostics company BioChain has licensed Epigenomics' methylated Septin9 marker, designed for the blood based detection of colorectal cancer (CRC). Under the license, BioChain will offer Septin9 assay as a service to customers ...
Tags: Clinical diagnostics, BioChain, Epigenomics